Loading the records…
Loading the records…
Marjorie Taylor Greene (R-GA) bought $1K-$15K of $AMZN (Amazon.com, Inc. - Common Stock) on Oct 24, 2025, part of 14 transactions in this filing.
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $AMZN | Amazon.com, Inc. - Common Stock | $1K-$15K | $224.21 | — | — | Oct 24, 2025 |
| BUY | $AMGN | Amgen Inc. - Common Stock | $1K-$15K | $291.76 | — | — | Oct 24, 2025 |
| BUY | $BRK.B | Berkshire Hathaway Inc. New Common Stock | $1K-$15K | — | — | — | Oct 24, 2025 |
| BUY | $BX | Blackstone Inc. Common Stock | $1K-$15K | $154.60 | — | — | Oct 24, 2025 |
| BUY | $CAH | Cardinal Health, Inc. Common Stock | $1K-$15K | $161.89 | — | — | Oct 24, 2025 |
| BUY | $CVX | Chevron Corporation Common Stock | $1K-$15K | $155.56 | — | — | Oct 24, 2025 |
| BUY | $HD | Home Depot, Inc. | $1K-$15K | $386.68 | — | — | Oct 24, 2025 |
| BUY | $IBIT | iShares Bitcoin Trust ETF - iShares Bitcoin Trust ETF | $1K-$15K | — | — | — | Oct 24, 2025 |
| BUY | $KMI | Kinder Morgan, Inc. Common Stock | $1K-$15K | — | — | — | Oct 24, 2025 |
| BUY | $MELI | MercadoLibre, Inc. - Common Stock | $1K-$15K | $2,161.11 | — | — | Oct 24, 2025 |
These bills and contracts share tickers or sectors with this filing's trades.
The CLOSE Act (HR6081) is an early-stage House bill that would eliminate the emission aggregation exemption for oil and gas wells under the Clean Air Act and require EPA to list hydrogen sulfide as a hazardous air pollutant. While the bill has 23 Democratic cosponsors and faces a long legislative path, it creates a regulatory overhang for U.S. E&P operators. Recent DPA energy executive orders (April 2026) conflict with the bill's direction, adding policy uncertainty.
The Lowering Drug Costs for American Families Act (HR6166) expands Medicare drug negotiation from 20 to 50 drugs and extends inflation rebates to commercial markets, targeting bearish revenue compression for major pharma ($MRK, $PFE, $LLY). Health insurers ($UNH, $CVS) face mixed effects — lower drug costs offset by new out-of-pocket caps. The bill is in early committee stage, giving markets time to price in the structural shift.
HR6485 (Skinny Labels, Big Savings Act) creates a statutory safe harbor protecting generic and biosimilar manufacturers from patent infringement liability when marketing drugs for non-patented indications, directly reversing the GlaxoSmithKline v. Teva precedent. Generic makers TEVA and VTRS are structural winners, with reduced litigation risk supporting their generic launch strategies. Brand-name manufacturers AMGN, PFE, JNJ, and MRK face accelerated competitive erosion on their top-selling drugs. The bill is early-stage (referred to House Judiciary), but companion Senate bill S43 signals bipartisan interest.
The Roadless Area Conservation Act of 2025 (S.2042) would permanently ban development on ~58.5 million acres of National Forest roadless areas, removing a major future source of federal timber supply. The bill is in committee with 25 cosponsors; passage probability is moderate. Real market data shows Weyerhaeuser ($WY) at $24.72 (near 52-week midpoint) and Louisiana-Pacific ($LPX) at $71.50 (near 52-week low), with both stocks declining over the past month. Near-term price impact is muted given the bill's early stage, but the structural supply constraint would be bullish for private timberland owners like $WY and bearish for federal-timber-dependent mills like some $LPX operations.
HR5868 extends grant eligibility for water utility cybersecurity training through 2031, but it is an early-stage authorization bill with no new funding and remains referred to committee. Cybersecurity stocks have recently rallied on unrelated factors—$CRWD +19.03% and $PANW +17.62% over 30 days—but this bill is procedural noise, not a catalyst.
The SUPPORT for Patients and Communities Reauthorization Act (P.L. 119-44) became law on December 1, 2025, extending federal substance use disorder and mental health funding through FY2030. This creates a structural tailwind for diagnostic testing (LH, DGX) and pharmaceutical distribution (CAH) via sustained grant programs, while also providing a positive policy backdrop for psychedelic therapy developers (CMPS, MNMD). Recent market data shows diagnostic stocks declining over the past 30 days, with LH at $261.79 (-1.88% 30d) and DGX at $193.52 (-1.26% 30d), suggesting the market has not yet priced in this long-term authorization catalyst.
The More Homes on the Market Act is an early-stage Senate bill (S. 3332) that would double the capital gains exclusion on primary residence sales to $500,000 for individuals and $1,000,000 for married couples, with inflation indexing. Filed December 3, 2025, the bill has been referred to the Senate Finance Committee and has not advanced. The limited legislative momentum means near-zero near-term market impact despite the structural benefit to homebuilders and mortgage banks if passed.
The CLEANER Act (HR6080) proposes reclassifying oil/gas drilling wastes as hazardous, directly increasing operating costs for US E&P companies like $XOM, $CVX, and $EOG while creating a new revenue stream for waste management firms $WM and $RSG. The bill is in early committee stage with 23 Democratic cosponsors — low probability of passage in the 119th Congress given Republican control, but the fundamental mechanism creates clear winners and losers. Recent market action shows energy stocks recovering from 30-day losses: $XOM at $154.67 (up 2.75% 7-day), $CVX at $192.22 (+2.46%), $EOG at $139.12 (+3.92%) — but the regulatory overhang, if this bill advances, would reverse that trend for producers.
The Revitalize Our Neighborhoods Act (HR6217) is an early-stage bill authorizing HUD competitive grants for blight elimination and neighborhood revitalization. It has zero funded dollars, is stuck in committee since November 2025, and presents no near-term market catalyst for homebuilders ($LEN, $DHI, $PHM) or retailers ($HD, $LOW). Real market data shows all five tickers have declined 2-4% in the past week, consistent with sector headwinds, not legislative activity.
S.3324 (FERC Greenhouse Gas and Environmental Justice Policy Act) directly increases regulatory hurdles for new natural gas pipeline and LNG approvals by mandating FERC consideration of climate and environmental justice impacts. This is bearish for midstream operators dependent on new FERC certificate projects, though the bill is in early stages and faces strong headwinds from competing Executive Orders under the DPA that seek to accelerate natural gas infrastructure development.
Free — no credit card
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.